Figure of the day: 43%
Of biotechnology company executives complain about the insufficiently low inflow of young professionals. This figure is presented in the newsletter “Biotechnology: organisations’ demand for R&D personnel and skills” published in the HSE ISSEK series “Science, Technology, and Innovation”.
-2%20%D0%B4%D0%B5%D0%B2%D1%83%D1%88%D0%BA%D0%B0%20%D0%B2%20%D0%BB%D0%B0%D0%B1%D0%BE%D1%80%D0%B0%D1%82%D0%BE%D1%80%D0%B8%D0%B8-%D0%B1%D0%B8%D0%BE%D1%82%D0%B5%D1%85.jpg)
Almost as many respondents (42%) noted the ageing of their companies’ personnel and a shortage of professionals with specific competencies (41%). A third of the surveyed (33%) complained about the inadequate skill level of young professionals. On the other hand, the outflow of professionals abroad wasn’t mentioned among the most acute problems: only 13% of the respondents believed it was an issue.
The publication is based on the results of an ISSEK survey comprising 80 large organisations and 27 biotechnology experts.
